作者：
Sosana,Delimpasi [1]
;
Meletios A,Dimopoulos [2]
;
Jan,Straub [3]
;
Argiris,Symeonidis [4]
;
Luděk,Pour [5]
;
Roman,Hájek [6]
;
Cyrille,Touzeau [7]
;
Viralkumar K,Bhanderi [8]
;
Jesus G,Berdeja [9]
;
Petr,Pavlíček [10]
;
Jeffrey V,Matous [11]
;
Pawel J,Robak [12]
;
Kaveri,Suryanarayan [13]
;
Alison,Miller [14]
;
Miguel,Villarreal [15]
;
Dasha,Cherepanov [16]
;
Jaydeep K,Srimani [17]
;
Huilan,Yao [18]
;
Richard,Labotka [19]
;
Robert Z,Orlowski [20]
作者单位：
Department of Hematology and Bone Marrow Transplantation Unit, General Hospital Evangelismos, Athens, Greece.
[1]
Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
[2]
Department of Internal Medicine - Hematology, University Hospital, Prague, Czech Republic.
[3]
Department of Hematology, University General Hospital of Patras, Patras, Greece.
[4]
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
[5]
Department of Haematooncology, University Hospital Ostrava and Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
[6]
University Hospital Hôtel Dieu, Nantes, France.
[7]
Florida Cancer Specialists, Tallahassee Cancer Center, Tallahassee, Florida, USA.
[8]
Sarah Cannon Research Institute, Nashville, Tennessee, USA.
[9]
Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
[10]
Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver, Colorado, USA.
[11]
Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.
[12]
Clinical Research, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
[13]
Statistics, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
[14]
Oncology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
[15]
Global Evidence and Outcomes (GEO), Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
[16]
Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
[17]
Precision and Translational Medicine, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
[18]
Oncology Clinical Research, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
[19]
Departments of Lymphoma/Myeloma and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
[20]
DOI
10.1002/ajh.27382
PMID
38856176
发布时间
2025-02-06
换一批
换一批
